Find Academic Supervisors

Mark ByrneView profile

Professor

• Biomaterials
• Drug Delivery Systems
• Silicone Hydrogels
• +2 more

Mark Byrne is a Professor of Biomedical Engineering at Rowan University's Henry M. Rowan College of Engineering. He holds a Ph.D. in Chemical Engineering from Purdue University and leads research on biomaterials for therapeutic applications. Laboratory facilities focus on polymer engineering and drug delivery system development. Research expertise includes biomimetic materials, therapeutic delivery systems, and ocular medical devices. Current projects develop extended-wear contact lenses for sustained drug delivery, nucleic acid nanocarriers for targeted therapy, and biodegradable nanogels for ophthalmic applications. Byrne collaborates with industry partners on silicone hydrogel materials and antimicrobial coatings. Recent publications demonstrate consistent focus on ocular drug delivery, including contact lens-based systems for sustained release (2022), nanocarriers for cataract treatment (2024), and polyelectrolyte complexes for ocular applications (2023). This work integrates material science with therapeutic objectives to improve treatment regimens. Laboratory capabilities include polymer synthesis, material characterization, and drug release testing. Industry partnerships include projects with Gelest Inc. on silicone hydrogel development and INOLEX on biomedical coatings.

Anthony LowmanView profile

Professor

• Drug Delivery
• Biomaterials
• Nanomaterials
• +2 more

Anthony Lowman is Professor and Provost/Senior Vice President for Academic Affairs at Rowan University's Henry M. Rowan College of Engineering. With PhD in Chemical Engineering from Purdue University, he leads research in biomaterials and drug delivery systems. His group develops hydrogels for therapeutic applications and medical devices. Research highlights: Design of injectable hydrogel composites Novel drug-eluting medical devices Oral delivery systems for biologics Polymer-based tissue engineering scaffolds Publications demonstrate strong focus on translational biomaterials, with recent patents covering hydrogel formulations and continuous delivery devices. Article keywords frequently involve polymer characterization, controlled release kinetics, and preclinical validation.

• Nanoparticle Engineering
• Biointerface Chemistry
• Drug Delivery Systems
• +3 more

Prof. Dr. Oya Tagit is a Lecturer and Team Leader of the BioInterfaces group at the Institute for Chemistry and Bioanalytics, part of the School of Life Sciences at FHNW University of Applied Sciences and Arts Northwestern Switzerland. Her research focuses on engineered nanoparticles and biointerfaces for biomedical applications, including drug delivery and cancer therapy. She has secured significant funding, including an EU Marie Sklodowska-Curie grant (NanoSense 2012-2014) and has been recognized with awards such as the Best Paper Award for her work on PLGA particles (2019). Her research spans nanomedicine, biomaterials, and therapeutic mechanisms, with a strong emphasis on translating lab-scale innovations into industrial applications. Key research interests include nanoparticle engineering for targeted drug delivery, modulation of biological systems, and the development of diagnostic tools. Her publications highlight advancements in nanocarriers, thermoresponsive materials, and neoantigen vaccines. She leads interdisciplinary projects involving continuous manufacturing processes and scale-up challenges in nanomedicine production. Awards and grants underscore her contributions to the field: the EU grant supported her work in Paris, while her 2019 paper on PLGA particles exemplifies her expertise in nanoparticle design and biological evaluation. Her team’s innovations bridge laboratory research with industrial applications, addressing scalability and clinical translation. Advising and grants include leadership in the BioInterfaces team and collaboration on EU-funded projects. Her work has implications for treating cancers, endocrine disorders, and improving diagnostic accuracy through nanotechnology.

Georg LippsView profile

Professor

• Protein Engineering
• Biochemistry
• Biotechnology
• +4 more

Prof. Georg Lipps is a faculty member at FHNW University of Applied Sciences in Switzerland, serving as Dean of the MSc in Life Sciences program and Team Leader of the Proteins and Enzymes research group. His primary affiliation is with the School of Life Sciences and the Institute for Chemistry and Bioanalytics. His career includes roles as Assistant Professor (2004-2007) and Substitute Professor (2007-2008) at the University of Bayreuth, Germany, and research positions in biochemistry and enzyme engineering. Education: Vordiplom (Bachelor) in Biology, University of Münster (1989) Diplom (Master) in Biochemistry, University of Witten-Herdecke (1992) PhD in Biochemistry, University of Giessen (1994) Habilitation in Biochemistry, University of Bayreuth (2004) Research Interests: Focuses on protein engineering, enzyme optimization for biotechnological applications, archaeal genetics (e.g., Sulfolobus species), and drug delivery systems. His work bridges fundamental biochemistry with applied research in thermostable enzymes and colonic drug delivery mechanisms. Grants & Collaborations: SNF grants for primase structure/function studies (2004–2023) CTI grants for enzyme-based drug development (2016–2023) Collaborations with institutions like ETH Zurich and DSM Nutritional Products Labs/Teams: Leads the Proteins and Enzymes team at FHNW, specializing in enzyme engineering and archaeal molecular biology. Active in interdisciplinary projects involving pharmaceutical and biotechnological applications.

Giuseppe PeraleView profile

Professor

• Biomaterials
• Tissue Engineering
• Drug Delivery Systems
• +3 more

Giuseppe Perale is a Full Professor of biomaterials at SUPSI (University of Applied Sciences and Arts of Southern Switzerland), where he heads the Biomaterials Laboratory and the Bio-Environmental Technology Laboratory within the Department of Innovative Technologies. He holds a Master’s degree and Ph.D. in Bioengineering and Industrial Biomedical Engineering from Politecnico di Milano (Italy). His research focuses on biomaterials for biomedical applications, including tissue engineering, controlled drug delivery, and regenerative medicine. Key projects include the SmartBonePep EuroStar Project (E!9624) and Swiss National KTI grants on bone substitutes and fracture fixation systems. He is an expert in resorbable materials like hydrogels and polymers, applying multidisciplinary approaches to sustainable medical device development. Education: Master’s (2002), Ph.D. (2006) in Bioengineering from Politecnico di Milano Leadership roles: Head of Biomaterials Lab & Bio-Environmental Technology Lab (SUPSI) Professional networks: Member of Inartis, TEDD, and BLV-3R initiatives His scientific contributions include over 100 publications, 3 patent families, and editor roles at Woodhead Publishing’s Biomaterials and Medical lists. Research highlights involve spinal cord regeneration, bone grafts, and drug delivery systems. Grants and collaborations include leadership in national and international projects, with a focus on translational research and industrial scalability. His work bridges applied physical chemistry, computational modeling, and clinical applications in neurology and orthopedics.

Patrick S. DoyleView profile

Professor

• Microfluidics
• Complex Fluids
• Polymer Physics
• +5 more

Patrick S. Doyle Patrick S. Doyle is the Robert T. Haslam (1911) Professor of Chemical Engineering at the Massachusetts Institute of Technology (MIT), affiliated with the Department of Chemical Engineering under the School of Engineering. His research focuses on microfluidics, complex fluids, polymer physics, and rheology with applications in drug delivery, environmental engineering, and biomaterials. He has pioneered innovations in hydrogel-based systems for pharmaceuticals and water treatment. Education Ph.D., Chemical Engineering, Stanford University, 1997 M.S., Chemical Engineering, Stanford University, 1993 B.S., Chemical Engineering, University of Pennsylvania, 1992 Research Interests Dr. Doyle’s work bridges chemical engineering and biotechnology, addressing challenges in: Design of stimuli-responsive materials (thermogels, nanoemulsions) Microfluidic fabrication of drug delivery systems Biofilm mechanics and bacterial behavior in marine environments High-resolution spatial profiling of microRNA in tissues Recent Research Trends Recent publications highlight advancements in: Hydrogel-based platforms for controlled release of antibodies and nanoparticles Engineered yeast systems for heavy metal remediation Zwitterionic hydrogels for multipollutant water treatment Topological control of DNA networks using confinement and flow Honors & Awards Notable recognitions include: Alpha Chi Sigma Award (2022) – AIChE’s highest research honor Multiple Singapore Research Professorships (2021, 2016, 2013) John Simon Guggenheim Fellowship (2009) Lab on a Chip Pioneers of Miniaturization Prize (2008) Grants & Advising Active grants include J-WAFS Seed Funding (2019) supporting water innovation. His Doyle Research Group has advised over 50 graduate students and postdocs, with notable alumni in academia and industry. Labs & Collaborations Leads the MIT Soft Matter Engineering Lab, collaborating with: Massachusetts General Hospital (cancer immunotherapy) Nanyang Technological University (water treatment) ESPCI Paris (DNA topology)

Brian AmsdenView profile

Professor

• Biomedical materials
• Medical devices
• Artificial tissues engineering
• +4 more

Brian Amsden is a Professor in the Department of Chemical Engineering at Queen's University, Canada. He holds the Donald and Joan McGeachy Chair in Biomedical Engineering and directs the Advanced Biomaterials Lab (ABiL). His research focuses on developing biodegradable polymers for biomedical applications, including drug delivery systems, soft tissue engineering, and regenerative medicine. Amsden's work involves collaborations with surgeons, mechanical engineers, and cell biologists to address challenges in orthopedics, cardiovascular systems, and ocular therapies. **Education**: Ph.D. (1996), Chemical Engineering, Queen's University M.A.Sc. (1991), University of Toronto B.A.Sc. (1988), University of Waterloo **Research Interests**: His laboratory investigates polymer degradation mechanisms, drug release dynamics, and cell-material interactions. Key areas include: Biodegradable elastomers and hydrogels for tissue regeneration Protein and peptide delivery systems (e.g., VEGF for therapeutic angiogenesis) Biomimetic scaffolds for ligaments and tendons Phototriggerable polymers for controlled drug activation **Awards & Affiliations**: Amsden is a Fellow of the Biomedical Engineering Society (FBSE) and leads initiatives like the CONNECT! NSERC CREATE Program in Soft Connective Tissue Engineering. His labs are affiliated with Queen's Centre for Health Innovation and the McGeachy Chair in Biomedical Engineering. **Grants & Supervision**: He has supervised over 50 graduate students and postdocs, with notable alumni such as Dr. Ronghui Qi (2023), Dr. Hossein Riahinezhad (2023), and Dr. Isaac Thevathasan. Current research includes projects funded by NSERC and industry partnerships. **Lab & Facilities**: His Advanced Biomaterials Lab integrates polymer synthesis, 3D printing (e.g., melt electrowriting), and in vivo testing to develop next-generation biomaterials for clinical translation.

• Pharmaceutical Technology
• Biopharmacy
• Nanomedicine
• +4 more

María Joséfa Alonso Fernández is a Professor of Pharmacy and Pharmaceutical Technology at the University of Santiago de Compostela (USC), affiliated with the Department of Pharmacology, Pharmacy, and Pharmaceutical Technology. She leads the NANOBIOFAR research group, focusing on nanotechnologies for drug delivery systems. Her work involves developing targeted therapies for cancer, autoimmune diseases, and HIV vaccines. She holds leadership roles in academic and scientific organizations, including editor-in-chief of Drug Delivery and Translational Research and former Vice-Rector for Research at USC. Her research has been supported by global entities like the Bill & Melinda Gates Foundation and the European Commission. Education: Pharmacy Degree, University of Santiago de Compostela (1981) PhD in Pharmaceutical Technology (1985) Research Interests: Design of nanocarriers for drug and vaccine delivery Targeted therapies for neurodegenerative diseases Thermostable vaccines and adjuvanted systems Oral delivery of biopharmaceuticals Awards: King Jaime I Award for New Technologies (2011) Castelao Medal (2018) National Research Award Juan de la Cierva (2022) Doctor honoris causa from the University of Nottingham (2022) Advancement Contributions: Founder of Spain’s first pharmaceutical nanotechnology lab Principal investigator for >50 international grants Co-developed HIV nanovaccines with global collaborators Labs/Teams: NANOBIOFAR Group at USC’s Faculty of Pharmacy Leading member of the Center for Research in Molecular Medicine and Chronic Diseases (CIMUS)

LUIS ANTONIO DIAZ GOMEZView profile

Professor

• Regenerative Medicine
• Drug Delivery Systems
• 3D Printing in Biomedical Applications
• +3 more

LUIS ANTONIO DIAZ GOMEZ is a Professor at the Department of Pharmacology, Pharmacy and Pharmaceutical Technology at the University of Santiago de Compostela (USC), affiliated with the Faculty of Pharmacy. He is part of the Materials Institute (iMATUS) and the Strategic Grouping in Materials (AEMAT). His research focuses on regenerative medicine, drug delivery systems, and advanced biomedical materials, with prominent contributions to 3D printed scaffolds and supercritical fluid processing. He completed his doctoral studies at USC in 2016, researching polymeric scaffolds for tissue regeneration under Dr. Ángel Concheiro Nine and Dr. Carmen Alvarez Lorenzo. His research interests span biomaterials design, tissue engineering, and controlled drug delivery. Key projects include developing 3D printed cellulose-based wound dressings, laser-assisted scaffold fabrication, and targeted therapies using nanotechnology. His work integrates advanced manufacturing techniques with biological applications, addressing challenges in bone regeneration, cancer treatment, and ocular drug delivery. Publications highlight innovations in scaffold design, prodrug strategies, and multimodal drug delivery systems. He collaborates with interdisciplinary teams to advance regenerative medicine and biomedical engineering. Current affiliations include the ID-FARMA research group, focusing on drug delivery systems and regenerative materials. While no specific scientific awards are listed in the text, his extensive publication record and research contributions reflect significant academic engagement in materials science and biomedical applications.

• Pharmaceutical Formulations
• Drug Delivery Systems
• Natural Products (Propolis, Plant Extracts)
• +3 more

Modestas Žilius is a Researcher at the Clinical Pharmacy Department and Pharmaceutical Technology Institute of the Lithuanian University of Health Sciences (Farmacijos fakultetas) . He holds a Doctor of Science degree (2014). His research focuses on pharmaceutical formulation development, particularly in drug delivery systems for natural products like propolis, plant extracts, and antioxidants. Key interests include optimizing extraction methods for phenolic compounds, evaluating biopharmaceutical properties of emulgels and hydrogels, and investigating skin permeation and topical applications for therapeutic agents. Education: PhD in Pharmacy (2014). His work emphasizes enhancing drug delivery efficiency through advanced formulations such as thermosensitive hydrogels, emulgels, and polymeric films. Notable projects include optimizing Agrimonia eupatoria phenolic extraction, developing Hippophae rhamnoides-based emulgels for atopic dermatitis, and creating Poloxamer 407 hydrogels for periodontal therapy. He also explores the therapeutic potential of cyanobacterial proteins like cyano-phycocyanin and investigates the role of proanthocyanidins in wound healing. Publications highlight interdisciplinary approaches in formulation science, combining experimental design (e.g., RSM), material characterization, and ex vivo/in vitro testing to ensure efficacy and safety. His contributions advance the translation of natural compounds into clinically viable topical treatments.

Dessi MalinovaView profile

Senior Lecturer

• Immunology
• Cell Biology
• Genetics
• +6 more

Dessi Malinova is a Senior Lecturer at the Wellcome Wolfson Institute for Experimental Medicine, part of the School of Medicine, Dentistry and Biomedical Sciences at Queen's University Belfast. She maintains an active research program with numerous publications and ongoing projects, and is currently accepting PhD students for immunology and immune cell biology research. Her research focuses on the mechanisms governing immune cell interactions, specifically examining immune synapse formation, endocytosis, and antigen presentation in B cells and dendritic cells. Dr. Malinova's work integrates immunology, cell biology, and genetics to understand fundamental immune processes. Her research fingerprint reveals significant contributions to areas including Actin, Antigen, B Cell, Immunodeficiency, Cytoskeleton, Mutation, Dendritic Cell, and Immunological Synapse research. Analysis of her recent publications shows a strong emphasis on B cell biology and antigen presentation mechanisms, with increasing application to disease contexts such as multiple myeloma. Her work spans fundamental immunological research through to translational applications in biomedical engineering and materials science, demonstrating interdisciplinary breadth while maintaining focus on immune cell function. Dr. Malinova actively supervises students and serves as an advisor on immunological research projects. She participates in significant collaborative research initiatives including the Future Medicines Institute (R1300CNR) and the Establishment of mass spectrometry based proteomic capabilities at Queen's University Belfast (R1127BSC). She is actively engaged in the immunology community, having served as Chair for the British Society for Immunology Congress in 2023 and as a Member of the Biotechnology & Biological Sciences Research Council. Her public engagement includes media appearances such as 'Women in Immunology' (2024) and 'RTE 10 things to know about' (2023).

• Nanomedicine
• Atherosclerosis Therapy
• Kidney Disease Treatment
• +5 more

Eun Ji Chung is an Associate Professor in the Department of Biomedical Engineering at the University of Southern California (Viterbi School of Engineering). Her research focuses on nanomedicine , targeted drug delivery systems , and biomaterials engineering . Her work addresses atherosclerosis , kidney diseases (e.g., polycystic kidney disease), and cardiovascular disorders . Key strategies include developing peptide-conjugated micelles , exosome-based therapies , and epigenetic-modulating nanoparticles . Research themes include: Designing kidney-targeting nanoparticles to treat genetic renal disorders Engineered extracellular vesicles for sustained therapeutic delivery miRNA-based therapies to repair endothelial barriers in atherosclerosis Immunomodulatory nanoparticles to inhibit inflammatory processes Recent work emphasizes sustainable biodegradable materials as industrial plastic alternatives and oral nanomedicine delivery systems for chronic diseases. Preclinical studies in mouse models have demonstrated efficacy in mitigating atherosclerotic plaque progression and kidney cyst formation. Her lab integrates nanoparticle engineering , in vivo biodistribution analysis , and molecular imaging techniques to advance translational medicine. Collaborations focus on transitioning lab discoveries into clinical therapies for cardiovascular and renal pathologies.

• 3D Bioprinting
• Drug Delivery Systems
• Pharmaceutical Materials Science
• +3 more

Professor Clive Roberts is a leading academic in the School of Life Sciences at the University of Nottingham, specializing in 3D bioprinting and pharmaceutical materials science. He leads the 'Biopill' work package of a £6M EPSRC-funded project collaboration across multiple universities and industries, aiming to develop 3D-printed medical devices like personalized pills and 'living plasters.' His research focuses on biomaterials, drug delivery systems, and regenerative medicine, leveraging additive manufacturing techniques. Key collaborations include partnerships with AstraZeneca, Pfizer, and institutions like Lawrence Livermore National Laboratory. He has contributed to projects addressing postoperative complications, antimicrobial resistance, and novel drug delivery mechanisms. His work spans interdisciplinary fields including polymer science, biomedical engineering, and materials characterization. Professor Roberts has published extensively on topics such as inkjet 3D printing of pharmaceuticals, controlled release systems, and biofilm-resistant composites. His research emphasizes translating innovations into clinical applications through partnerships with industry and academic institutions.

• Polymer Science
• Drug Delivery
• Tissue Engineering
• +3 more

Brent Vernon is an Associate Professor and undergraduate program chair in biomedical engineering at Arizona State University (ASU), where he also directs the Center for Interventional Biomaterials. He holds affiliations with the School of Biological and Health Systems Engineering and the School of Life Sciences. His research focuses on polymer science and chemistry to design in situ gelling materials for drug delivery, tissue engineering, and vascular applications such as embolization. Education: Ph.D. in Bioengineering from the University of Utah (1999). Research Interests: Biomaterials development, hydrogels, temperature-responsive polymers, and their applications in medical devices and drug delivery systems. Notable projects include injectable hydrogels for endovascular embolization and antimicrobial hydrogels for surgical site infection prevention. Key Grants: Includes NIH-funded studies on bioresponsive copolymers and NSF-supported materials research. Collaborations with institutions like Mayo Clinic and Banner Good Samaritan Medical Center. Teaching: Courses include biomedical engineering capstone design, tissue engineering, and biomaterials. Active in mentoring undergraduate and graduate research projects. Service: Referee for journals like Biomaterials and Advanced Materials ; member of professional organizations including the Controlled Release Society and Biomedical Engineering Society.

• Materials Science
• Polymer Chemistry
• Biomaterials
• +4 more

Professor Tim Dargaville is a Professor in the School of Chemistry & Physics at Queensland University of Technology (QUT). He leads research in polymer chemistry and biomaterials, focusing on biomedical applications such as drug delivery systems, tissue engineering, and medical device development. His work includes developing polymer scaffolds for skin and percutaneous devices, as well as novel materials for diabetes and koala chlamydia treatments. Education: PhD (Chemistry) from the University of Queensland. Professional affiliations include the Australasian Society of Biomaterials and Tissue Engineering (ASBTE), Royal Australian Chemical Institute (RACI), and American Chemical Society. Research interests span polymer synthesis, characterization, and biomedical applications. Key areas include surface-modified polymers, radiation effects on materials, and poly(2-oxazoline) biomaterials. Recent projects involve polymer scaffolds for pancreatic islet viability and chlamydia vaccines for koalas. Publications (selected): Over 110 papers, including work on liposome drug delivery, melt electrowriting scaffolds, and pH-responsive nanoparticles. Research trends emphasize biomaterials for infection control, 3D printing of resorbable networks, and advanced drug delivery mechanisms. Grants: Multiple Australian Competitive Grants (e.g., FT150100408, DP120104611) for projects on biomaterials and immunology, composite biomaterials, and growth factor signaling. Collaborates with hospitals, labs, and companies for materials testing and formulation. Labs/Teams: Centre for Materials Science at QUT, leading interdisciplinary teams in polymer design and biomedical applications.